Phase 1 Acute Spinal Cord Injury Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
NVG-291 in Spinal Cord Injury Subjects
chronic spinal cord injurySpinal Cord InjuriesSubacute Spinal Cord Injury
NervGen Pharma40 enrolled1 locationNCT05965700
Recruiting
Phase 1
Spinal Cord Injury Neuroprotection With Glyburide
Acute Spinal Cord Injury
Francis Farhadi12 enrolled1 locationNCT05426681
Recruiting
Phase 1Phase 2
Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury
Acute Spinal Cord Injury (SCI)
Technophage, SA28 enrolled2 locationsNCT06677229
Recruiting
Phase 1
NG004 in Spinal Cord Injury Patients
Central Nervous System DiseasesNervous System DiseasesTrauma, Nervous System+4 more
NovaGo Therapeutics AG21 enrolled6 locationsNCT06817577